1-855-378-42281-855-378-4228
One of the out-patient rehabilitation alternatives for individuals in Troy who are struggling with opioid dependence and addiction is opioid maintenance therapy. Licensed facilities and doctors are authorized to dispense certain medications to opioid addicted individuals, many of which are opioid-based also and are habit forming. With low enough amounts however, the individual does not feel high and also does not experience intense cravings and is not experiencing opioid withdrawal. Methadone is the first med used for this purpose, but there are other choices currently to select from.
Methadone is an opiate and is meant to be taken at an outpatient medical center licensed to dispense the drug, that is taken daily in liquid or pill form. The cost of the med is around one hundred and fifty dolloars a month. Buprenorphine is also an opiate based drug, and is in pill form often taken one day on, one day off. But different from Methadone that is only be given in well-regulated medical centers, Buprenorphine can be prescribed and dispensed in doctor's offices. The monthly cost of buprenorphine is approximately $300.00 monthly for the generic of the drug. There is also a type of buprenorphine containing the drug naloxone, that is a med that reverses the effects of opiates. Someone consuming this formulation, also known as Suboxone, would find it harder to feel high from opioids if they relapsed while taking the drug. It is also taken on a daily basis, and is priced about $450 monthly. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other drugs aforementioned it is an opioid blocker and is not an opiate. A person has the choice to take this drug as a monthly shot, which is called Vivitrol. As an opioid blocker, the drug prevents someone from feeling high from opioids, and in turn lowers the risk associated with relapse. This daily injection costs anywhere from $1000 to $1200 /month.
For All Drug and Alcohol Rehabilitation Programs In Troy, Click Here.
